The Brussels-based European Alliance for Personalised Medicine (EAPM), sixth annual Presidency conference, which will take place under the auspices of the Bulgarian Presidency of the European Union March 28th 2018, entitled 'Personalised Medicine and the Big Data Challenge'.

This will take place in the Belgian capital, at the prestigious Bibliothèque Solvay, close to the Brussels seat of the European Parliament.

As was the case last year, the conference will be highly interactive with roundtable sessions and several Q and A opportunities to enhance involvement from the floor. The mix of its members provides extensive scientific, clinical, caring and training expertise in personalised medicine and diagnostics, across patient groups, academia, health professionals and industry.

Relevant departments of the Commission have observer status, as does the EMA. This conference, albeit under the Big Data umbrella, will also have a focus on disease areas and see the following sessions among others:

• Broad picture of profiling/genomics/personalised healthcare • More data to treat more diseases • Commissioners' discussions • Haematology/Oncology • How can the region and national level integrate this

Leading scientists and cutting-edge SMEs in Europe and Australia teamed up in the EU-funded STELLAR project. Their mission? Explore the regenerative potential of new cell types for tackling chronic kidney disease, develop methods to exploit it, and tools to promote the findings, including a dedicated song, of all things!

A potential drawback of clinical trials of new drugs is that they do not always reflect how well these will work in the 'real world'. EU and industry-funded research brought together key stakeholders to help add more such evidence into the design of trials, increasing confidence in new medicines and helping to get them to patients more quickly.

The human brain produces, processes and transmits information in an incomparable manner. Researchers and scientists from all over the world strive to decode the mechanisms underlying this multi-layered and unique system.

The Human Brain Project is a major driving force in the field of neuroscience research in Europe, aiming to model the brain and reproduce its complexity on computing platforms.

This one-day event especially targets early career researchers and provides an overview of elements of brain modelling tools both from software and hardware perspectives.

The programme comprises several sessions where participants get ample opportunities to exchange information and knowledge with peers as well as renowned experts working in the Human Brain Project. Attendance is free, but registration is required.

Co-organised by: Human Brain Project Bulgarian Academy of Sciences Registration deadline: 9 April 2018

An EU-and industry-funded project has created an integrated platform which is providing an innovative range of free services, expertise and a huge collection of compounds for researchers who are developing new drugs to treat all types of human diseases.

Using innovative nanotechnologies, an EU-funded project is developing more efficient and sustainable vaccine manufacturing processes. The cost of vaccines puts a brake on wider immunisation, so these new processes will find broad application - especially in developing economies.

Science Café with František Štěpánek is an unconventional open discussion with theme "Future of microscopic robots".

Prof. František Štěpánek is a recognized scientist in the field of chemical engineering. His research is focused on microscopic chemical robots that mimic single-cell organisms. One of the main drivers for the development of chemical robots is the area of oncology, and especially controlled and targeted delivery of chemotherapeutics to tumours, along with the related diagnostics and control.

Currently Prof. František Štěpánek leads the Chemical Robotics Laboratory at the University of Chemistry and Technology, Prague. In 2008, Prof. Štěpánek became the first ERC grantee in the Czech Republic.

Science Café is a forum for discussion of current work and interesting scientific issues. It aims to be informal and accessible. Anyone can participate; speaker is there to be questioned and to talk about his work.

Research team from the Institut de Recherche pour le Développement in France, led by Prof Alexandre Dumont, won the first €1 million Horizon Birth Day Prize for their work that has cut the number of deaths of new mothers in hospitals in Mali and Senegal by as much as a third.

An EU-funded project has created an airbag bike helmet that is eight times safer than its traditional counterparts. It is both comfortable and attractive in a bid to motivate more people to cycle responsibly.

EU-funded researchers are developing a personalised dosing solution for chemotherapy targeting leukaemia using advanced microfluidic chips to meet the precise medical requirements of individual patients.

This two-day awareness session for international regulators and non-governmental organisations (NGOs) will give an insight into how the European medicines regulatory network works, the role of European Medicines Agency (EMA), scientific aspects of EMA's work and its interaction with scientific experts.

It will address topics including the role of experts and benefit-risk evaluation. It will also provide networking opportunities with academics, NGOs staff and regulators from and outside the European Union.

The event will be broadcast live. EMA will publish further material after the event

An EU-funded project has created easy-to-use, active computer games that can help build new nerve cell connections in stroke patients' brains and allow for a more flexible and cheaper home-based recovery.

Billions of euros are wasted ever year on research that is redundant, flawed, never published or poorly reported. The EU-funded project MIROR aims to reduce this waste and ensure money invested in medical research is well spent on achieving results that matter to people.

An EU-funded project has provided new hope for the 2 million people in Europe who suffer from rare kidney diseases thanks to groundbreaking research that has led to diagnostic tests and a new type of treatment.

EU-funded researchers have developed a treatment tailored for babies and children lacking the stress hormone cortisol. The drug, the first hydrocortisone formulation specifically designed for infants, could become available next year following successful clinical trials.

EU-funded researchers have uncovered how venomous sea snails manufacture organic molecules with important applications in treatments for pain relief and diabetes. This basic research also offers unexpected, new insights into the field of cell biology.

For the ninth time, the conference invites researchers and entrepreneurs from North Rhine-Westphalia and regions in Europe to find new European Research & Innovation (R&I) partners for Horizon 2020 projects.

The series of events has been a great success with over 2300 participants since 2009. The event addresses especially universities and research institutes and small and medium-sized enterprises.

Participants, who are interested in giving a presentation, can participate in the "Call for Presentations" (ideas for H2020 projects and/or results from former international R&D&I projects).

The H2020 MSCA ETN Network List_MAPS welcomes you to its symposium which will be held in the historic town of Kinsale, on the south coast of Ireland on Thrusday 26th April 2018.

Contamination of foodstuff by pathogenic microorganisms is a major safety issue and a burden to the food industry. Many routes may lead to food contamination from farm to fork.

The symposium will address several facets of the ecology of foodborne pathogens.

Most rare diseases are linked to specificities of the patients' genes - but what these are, exactly, remains to be determined for the vast majority of these illnesses. Tackling this challenge, an EU-funded platform is helping to generate answers from as few as two known cases by enabling scientists to pool and compare genomic and clinical data.

We are pleased to invite you to the kick-off meeting of the strategic project of ten leading life science institutions from nine EU-13 countries.

The main objective of the event is to present Alliance4Life, a bottom-up initiative aimed at closing the divide in European health research and innovation. Alliance4Life intends to become a role model for institutions in less performing regions and to serve as a hub of excellence through close collaboration with renowned European networks established in high performing countries.

The initiative is supported by the Coordination Action „Alliance for Life Sciences: Closing Research and Innovation Divide in the EU“ under H2020 and coordinated by Central European Institute of Technology (CEITEC).